Takeda A, Tomita Y, Matsunaga J, Tagami H, Shibahara S
Department of Applied Physiology, Tohoku University School of Medicine, Miyagi, Japan.
J Biol Chem. 1990 Oct 15;265(29):17792-7.
Tyrosinase-negative oculocutaneous albinism (OCA) is one of classical inborn errors of metabolism, characterized by a complete lack of melanin pigments in the eyes and skin. We have isolated and characterized the tyrosinase gene of one child (F. S.) affected with tyrosinase-negative OCA. Sequence analysis reveals a single-base mutation in the exon 1 (a G to A transition at nucleotide residue 312), causing the Arg (CGG) to Gln (CAG) substitution at position 59. This base change eliminates one MspI site and creates a new BstNI site in the patient's exon 1, which is invaluable for screening other OCA patients and heterozygote carriers for this mutation. We are thus able to confirm that the patient F. S. is homozygous for this OCA allele. The family members of the patient F. S. are phenotypically normal, but are shown to be heterozygote carriers. Transfection of the mutant gene fails to give rise to detectable tyrosinase activity in transient expression assays, suggesting that the mutation affects the stability or the catalytic activity of the enzyme. We therefore propose that the albino phenotype of the patient F. S. is a consequence of the Arg to Gln substitution at position 59 caused by a point mutation in the tyrosinase gene.
酪氨酸酶阴性眼皮肤白化病(OCA)是一种典型的先天性代谢缺陷病,其特征是眼睛和皮肤完全缺乏黑色素。我们已经分离并鉴定了一名患有酪氨酸酶阴性OCA的儿童(F.S.)的酪氨酸酶基因。序列分析显示外显子1存在单碱基突变(核苷酸残基312处的G到A转换),导致第59位的精氨酸(CGG)被谷氨酰胺(CAG)取代。这种碱基变化消除了一个MspI位点,并在患者的外显子1中产生了一个新的BstNI位点,这对于筛查其他OCA患者和该突变的杂合子携带者非常有价值。因此,我们能够确认患者F.S.对于该OCA等位基因是纯合的。患者F.S.的家庭成员表型正常,但被证明是杂合子携带者。在瞬时表达试验中,突变基因的转染未能产生可检测到的酪氨酸酶活性,这表明该突变影响了酶的稳定性或催化活性。因此,我们认为患者F.S.的白化病表型是由酪氨酸酶基因中的点突变导致第59位精氨酸被谷氨酰胺取代的结果。